Pharvaris N.V. PHVS
Annual
Quarterly
No annual revenue total was found in Pharvaris N.V.'s SEC filings.
Pharvaris N.V. (PHVS) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
65.21M
+19.9% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PHVS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Leiden
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1830487
- Former names
- Pharvaris, B.V. (until Feb 4, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Aug 12, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 26, 2026 | Jun 26, 2026 |
| 6-K | Current report (foreign issuer) | Jun 11, 2026 | Jun 11, 2026 |
| 6-K | Current report (foreign issuer) | May 12, 2026 | May 12, 2026 |
All 327 Pharvaris N.V. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.